A placebo-controlled trial of astaxanthin in subjects with nonalcoholic fatty liver disease
Not Applicable
Recruiting
- Conditions
- onalcoholic fatty liver disease (NAFLD)
- Registration Number
- JPRN-UMIN000008524
- Lead Sponsor
- Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects who 1) are infected with HBV or HCV 2) have alcohol intake more than 30 for male, and more than 20 gram for female 3) have malignant tumor including hepatocellular carcinoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum alanine aminotransferase level
- Secondary Outcome Measures
Name Time Method Histologic features of nonalcoholic steatohepatitis